This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Asia-Pacific Molecular Biology Network | |
|---|---|
| Name | Asia-Pacific Molecular Biology Network |
| Formation | 1990s |
| Type | Non-governmental organization |
| Headquarters | Singapore |
| Region served | Asia-Pacific |
| Language | English |
Asia-Pacific Molecular Biology Network is a regional association that connects laboratories, universities, and institutes across the Asia-Pacific region including links with National University of Singapore, University of Tokyo, Peking University, Indian Institute of Science and University of Sydney. It fosters cooperation among entities such as the Wellcome Trust, World Health Organization, Asian Development Bank, Australian National University and Chinese Academy of Sciences to advance molecular biology research, training, and policy. The Network engages partner institutions like Harvard University, Max Planck Society, Stanford University, University of Cambridge and Karolinska Institutet to build regional capacity and collaborative projects.
The Network was initiated during dialogues involving representatives from Asia-Pacific Economic Cooperation, Association of Southeast Asian Nations, UNESCO, International Union of Biochemistry and Molecular Biology and national bodies such as Ministry of Health (Singapore), Ministry of Science and Technology (China), Department of Biotechnology (India), Korea Institute of Science and Technology and National Institutes of Health (United States). Early milestones included memoranda with Genome Canada, Institut Pasteur, Wellcome Trust Sanger Institute, European Molecular Biology Laboratory and Cold Spring Harbor Laboratory, and workshops hosted at National University of Singapore, University of Tokyo, Tsinghua University, Monash University and University of Hong Kong. The formative period overlapped global initiatives led by Human Genome Organization, Global Virus Network, Bill & Melinda Gates Foundation, Centers for Disease Control and Prevention and World Bank.
Membership spans universities and institutes such as University of Auckland, University of Otago, University of Malaya, Chulalongkorn University, National Taiwan University, Seoul National University, Kyoto University and Fudan University. Affiliate partners include Riken, CSIRO, Indian Council of Medical Research, Korea Research Institute of Bioscience and Biotechnology, Pasteur Institute of Ho Chi Minh City and MRC Laboratory of Molecular Biology. The Network liaises with funding bodies like Wellcome Trust, Gates Foundation, Australian Research Council, National Natural Science Foundation of China and Japan Society for the Promotion of Science, and coordinates with regional agencies such as ASEAN Secretariat, SAARC, Pacific Islands Forum and ADB.
Core activities feature collaborative consortia with Human Frontier Science Program, Horizon 2020, NIH Fogarty International Center, Bill & Melinda Gates Foundation initiatives, and capacity-building schemes with UNESCO, WHO Regional Office for the Western Pacific, Wellcome Trust Asia Program, International Centre for Genetic Engineering and Biotechnology and European Molecular Biology Organization. It runs thematic networks connecting genomics centers at Genome Institute of Singapore, Beijing Genomics Institute, Korean National Institute of Health and CSIR laboratories, and convenes conferences alongside Cold Spring Harbor Laboratory Asia, EMBO workshops, Gordon Research Conferences, Keystone Symposia and Asia-Pacific Biotech Summit.
Research collaborations include multi-site projects with National Institutes of Health, European Commission, Wellcome Trust Sanger Institute, Broad Institute, Riken Center for Integrative Medical Sciences and Genome Canada on topics aligning with programs at Tata Institute of Fundamental Research, Indian Institute of Technology Bombay, Ludwig Institute for Cancer Research and Peter Doherty Institute. Joint publications have been produced with authors from Peking University, University of Tokyo, Monash University, Seoul National University Hospital and Singapore General Hospital, and partnerships extend to translational links with Duke-NUS Medical School, Imperial College London, Yale School of Medicine, Johns Hopkins University and McGill University.
Training initiatives partner with EMBO, Federation of Asian Biotech Associations, Cold Spring Harbor Laboratory, Wellcome Trust Sanger Institute and national academies such as Indian National Science Academy, Chinese Academy of Sciences', Royal Society (United Kingdom), Australian Academy of Science and Academia Sinica. Workshops and fellowships engage trainees from Bangladesh University of Engineering and Technology, University of Colombo, University of the Philippines, Universidad de Chile, University of Papua New Guinea and University of the South Pacific alongside exchanges with Stanford University School of Medicine, Cambridge University Hospitals and Karolinska Institutet.
Governance comprises a council with representatives from National University of Singapore, University of Tokyo, Peking University, Indian Institute of Science, University of Sydney, Fudan University and Seoul National University, and advisory boards including experts from WHO, UNESCO, Wellcome Trust, Bill & Melinda Gates Foundation and European Molecular Biology Laboratory. Funding streams derive from grants awarded by Wellcome Trust, Bill & Melinda Gates Foundation, Asian Development Bank, National Institutes of Health, Japan International Cooperation Agency, European Commission and partner universities such as University of Oxford and Harvard Medical School.
Notable projects include regional surveillance consortia linked with WHO Global Influenza Programme, Global Influenza Surveillance and Response System, Global Virus Network, COVID-19 Genomics UK Consortium collaborations, and biodiversity genomics efforts with International Barcode of Life, Earth BioGenome Project, GBIF and Convention on Biological Diversity partners. The Network has supported translational programs tied to malaria initiatives run by PATH, Medicines for Malaria Venture, Wellcome Trust Tropical Unit and vaccine research with National Institute of Infectious Diseases (Japan), Serum Institute of India and Osaka University. It has influenced policy dialogues involving ASEAN, APEC, UNESCO, WHO and G7 science tracks, and produced outputs recognized by awards such as Lasker Award, Nobel Prize in Physiology or Medicine, Japan Prize and Shaw Prize through collaborations with laureates and institutions.
Category:Scientific organizations